IDEAYA Biosciences (IDYA) Current Assets (2018 - 2026)

IDEAYA Biosciences has disclosed Current Assets across 9 years of filings, most recently posting $696.1 million for Q1 2026.

• Current Assets for Q1 2026 came in at $696.1 million, down 1.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $696.1 million (down 1.66% YoY), and the FY2025 annual result was $666.7 million, down 3.33% from the prior year.
• Current Assets came in at $696.1 million for Q1 2026 at IDEAYA Biosciences, up from $666.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $932.2 million in Q3 2024 to a low of $256.0 million in Q1 2022.
• The 5-year median for Current Assets is $666.7 million (2025), against an average of $573.9 million.
• Across the five-year window, Current Assets slipped 16.91% in 2022 and surged 106.23% in 2024, its largest moves.
• IDEAYA Biosciences' Current Assets stood at $370.5 million in 2022, then surged by 43.78% to $532.6 million in 2023, then advanced by 29.49% to $689.7 million in 2024, then retreated by 3.33% to $666.7 million in 2025, then advanced by 4.41% to $696.1 million in 2026.
• The last three Current Assets figures came in at $696.1 million (Q1 2026), $666.7 million (Q4 2025), and $802.7 million (Q3 2025), per Business Quant data.